This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahata, S. K. Articles by O’Connor, D. T. Search for Related Content PubMed PubMed Citation Articles by Mahata, S. K. Articles by O’Connor, D. T.

Neuroendocrine Cell Type-Specific and Inducible Expression of the Secretogranin II Gene: Crucial Role of Cyclic Adenosine Monophosphate and Serum Response Elements¹

Department of Medicine and Center for Molecular Genetics (S.K.M., M.M., C.V.L., D.T.O’C.), University of California, and San Diego VA Healthcare System, San Diego, California 92161; and Department of Neurobiology, Heidelberg University (H.-H.G., W.B.H.), Heidelberg, Germany

Address all correspondence and requests for reprints to: Sushil K. Mahata, Ph.D., Department of Medicine and Center for Molecular Genetics (9111H), University of California, San Diego, 3350 La Jolla Village Drive, San Diego, California 92161-9111H. E-mail: smahata{at}ucsd.edu

Secretogranin II, an acidic protein in the chromogranin/secretogranin family, is widely distributed in neuroendocrine secretory granules. What factors govern such widespread, yet selective, expression? The 5' deletions localized neuroendocrine cell type-specific expression to the proximal mouse secretogranin II promoter: such expression was abolished after deletion past the cAMP response element (CRE; [-67 bp]TGACGTCA[-60 bp]), and transfer of the CRE to a neutral promoter conferred 3.4- to 5.3-fold neuroendocrine selectivity. Thus, the CRE is, at least partly, sufficient to confer tissue-specific expression. Substantial (48–59%) loss of cell type-specific expression also occurred upon deletion past the serum response element (SRE; [-302 bp]GATGTCC[-296 bp]), and transfer of the SRE to a neutral promoter also conferred neuroendocrine selectivity. Expression of both the endogenous gene and the transfected secretogranin II promoter was up-regulated after secretagogues, and the degree of trans-activation of the transfected promoter (2.2- to 5.4-fold) paralleled activation of the endogenous gene (1.8- to 3.2-fold). The 5' promoter deletions revealed complete loss of secretagogue responses after deletion past the CRE. Transfer of the CRE to a neutral promoter conferred secretagogue responses (by 2.2- to 18.6-fold). Substantial (59–74%) falls in secretagogue responses also occurred after deletion past the promoter’s SRE. Transfer of the SRE to a neutral promoter conferred secretagogue responses (by 2.7- to 8.3-fold). We conclude that the CRE is a crucial determinant of cell type-specific constitutive and secretagogue-inducible expression of the secretogranin II gene and that the SRE also plays a substantial role in both processes.

This article has been cited by other articles:

				N. R. Mahapatra, M. Mahata, D. T. O'Connor, and S. K. Mahata Secretin Activation of Chromogranin A Gene Transcription: IDENTIFICATION OF THE SIGNALING PATHWAYS IN CIS AND IN TRANS J. Biol. Chem., May 23, 2003; 278(22): 19986 - 19994. [Abstract] [Full Text] [PDF]

				L. Taupenot, K. L. Harper, and D. T. O'Connor The Chromogranin-Secretogranin Family N. Engl. J. Med., March 20, 2003; 348(12): 1134 - 1149. [Full Text] [PDF]

				Y. Sakai, M. Hosaka, Y. Hira, T. Harumi, Y. Ohsawa, H. Wang, T. Takeuchi, Y. Uchiyama, and T. Watanabe Immunocytochemical Localization of Secretogranin III in the Anterior Lobe of Male Rat Pituitary Glands J. Histochem. Cytochem., February 1, 2003; 51(2): 227 - 238. [Abstract] [Full Text] [PDF]

				V. Turquier, L. Yon, L. Grumolato, D. Alexandre, A. Fournier, H. Vaudry, and Y. Anouar Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells through Multiple Signaling Pathways and Increased Binding of Pre-Existing Activator Protein-1-Like Transcription Factors Mol. Pharmacol., July 1, 2001; 60(1): 42 - 52. [Abstract] [Full Text]

				N. R. Mahapatra, M. Mahata, A. K. Datta, H.-H. Gerdes, W. B. Huttner, D. T. O'Connor, and S. K. Mahata Neuroendocrine Cell Type-Specific and Inducible Expression of the Chromogranin B Gene: Crucial Role of the Proximal Promoter Endocrinology, October 1, 2000; 141(10): 3668 - 3678. [Abstract] [Full Text] [PDF]